Characterization of granulocytic ehrlichia and methods of use
The present invention relates, in general, to granulocytic ehrlichia (GE) proteins. In particular, the present invention relates to nucleic acid molecules coding for GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins; purified GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins; a method of detecting nucleic acids encoding GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins or polypeptides in a sample; kits containing nucleic acid probes or antibodies; bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess, or prognose a mammal afflicted with ehrlichiosis; therapeutic uses, specifically vaccines comprising S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins or polypeptides or nucleic acids; and methods of preventing or inhibiting ehrlichiosis in an animal.
1. A purified polypeptide having an amino-terminus comprising the amino acid sequence set forth in SEQ ID NOS:27, 29, or 30 and/or having a carboxy-terminus comprising the amino acid sequence set forth in SEQ ID NOS:27, 29, or 30.
2. A method of detecting an antibody to a S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, or E46#2 polypeptide in a sample, comprising:
(a) contacting said sample with a polypeptide consisting of an amino acid sequence set forth in SEQ ID NOs: 4, 6, 2, 8, 21, 22, 39, 27, 29, or 30, corresponding to S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, or E46#2, respectively, under conditions such that immunocomplexes form; and
(b) detecting the presence of said polypeptide bound to said antibody.
3. A diagnostic kit comprising: a container means containing a polypeptide consisting of an amino acid sequence set forth in SEQ ID NOS: 4, 6, 2, 8, 21, 22, 39, 27, 29, or 30, or a polypeptide of claim 1 .
4. A polypeptide consisting of an amino- or carboxy-terminal conserved region of granulocytic Ehrlichia E8 polypeptide.
5. The polypeptide of claim 4 which consists of the amino-terminal conserved region of granulocytic Ehrlichia E8 polypeptide.
6. The polypeptide of claim 5 , wherein the amino-terminal conserved region corresponds to amino acids 1-207 of SEQ ID NO:27.
7. The polypeptide of claim 5 , wherein the amino-terminal conserved region comprises the amino acid sequence of SEQ ID NO:69.
8. The polypeptide of claim 4 which consists of the carboxy-terminal conserved region of granulocytic Ehrlichia E8 polypeptide.
9. The polypeptide of claim 8 , wherein the carboxy-terminal conserved region comprises the amino acid sequence of SEQ ID NO:70.
10. A polypeptide which is encoded by a nucleotide sequence contained within nucleotides 232 to 760 of SEQ ID NO:26, wherein the polypeptide is an immunogenic or antigenic epitope.
11. The polypeptide of claim 10 , wherein the immunogenic or antigenic epitope comprises the amino acid sequence SEQ ID NO:69.
12. The polypeptide of claim 10 , wherein the immunogenic or antigenic epitope comprises the amino acid sequence SEQ ID NO:70.
13. A diagnostic kit comprising: a container means containing the polypeptide of any one of claims 4 - 12 .
14. A method of detecting an antibody to granulocytic Ehrlichia E8 polypeptide in a sample, comprising:
(a) contacting said sample with the polypeptide of any one of claims 4 - 12 , under conditions such that immunocomplexes form; and
(b) detecting the presence of said immunocomplexes, thereby detecting said antibody to granulocytic Ehrlichia E8 polypeptide in said sample.
15. A composition comprising a polypeptide of any one of claims 4 - 12 .